Form 4: Encompass Health Director Acquires Additional Shares Through Dividend Reinvestment
SEC Form 4
Director Donald L. Correll acquired 184 shares of Encompass Health Corp through a dividend reinvestment program.
Summary
- Donald L. Correll, a director of Encompass Health Corp, acquired 184 shares of common stock on April 15, 2024.
- The acquisition was a result of dividend payments on outstanding restricted stock units (RSUs).
- The dividend paid was $0.15 per share, and the closing price of Encompass Health's common stock on the dividend payment date was $80.73.
- Following the transaction, Correll beneficially owns 99,938 shares of Encompass Health common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to dividend reinvestment, indicating stability but not necessarily strong growth or decline.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This type of transaction is common for directors who hold restricted stock units and participate in dividend reinvestment programs. It's a standard way for executives to increase their holdings in the company.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it's a small acquisition of shares by a director.
Key Dates
| Date | Description |
|---|---|
| 04/15/2024 | Date of transaction: Acquisition of 184 shares of Encompass Health common stock due to dividend reinvestment. |
| 04/16/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.